Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
Eiger BioPharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
28249U105
(CUSIP Number)
December 31, 2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
This Schedule is filed pursuant to Rule 13d-1(b)
The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
| CUSIP NO. 28249U105 |
| 1) |
Name of Reporting Person Ameriprise Financial, Inc.
S.S. or I.R.S. Identification No. of Above Person IRS No. 13-3180631 | |||||
| 2) | Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☒*
| |||||
| 3) | SEC Use Only
| |||||
| 4) | Citizenship or Place of Organization
Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5) | Sole Voting Power
0 | ||||
| 6) | Shared Voting Power
3,676,760 | |||||
| 7) | Sole Dispositive Power
0 | |||||
| 8) | Shared Dispositive Power
3,921,835 | |||||
| 9) |
Aggregate Amount Beneficially Owned by Each Reporting Person
3,921,835 | |||||
| 10) | Check if the Aggregate Amount in Row (9) Excludes Certain Shares
Not Applicable | |||||
| 11) | Percent of Class Represented by Amount In Row (9)
12.06% | |||||
| 12) | Type of Reporting Person
HC | |||||
| * | This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group. |
| CUSIP NO. 28249U105 |
| 1) |
Name of Reporting Person Columbia Management Investment Advisers, LLC
S.S. or I.R.S. Identification No. of Above Person IRS No. 41-1533211 | |||||
| 2) | Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☒*
| |||||
| 3) | SEC Use Only
| |||||
| 4) | Citizenship or Place of Organization
Minnesota | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5) | Sole Voting Power
0 | ||||
| 6) | Shared Voting Power
3,676,760 | |||||
| 7) | Sole Dispositive Power
0 | |||||
| 8) | Shared Dispositive Power
3,919,785 | |||||
| 9) |
Aggregate Amount Beneficially Owned by Each Reporting Person
3,919,785 | |||||
| 10) | Check if the Aggregate Amount in Row (9) Excludes Certain Shares
Not Applicable | |||||
| 11) | Percent of Class Represented by Amount In Row (9)
12.05% | |||||
| 12) | Type of Reporting Person
IA | |||||
| * | This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group. |
| 1(a) | Name of Issuer: | Eiger BioPharmaceuticals, Inc. | ||
| 1(b) | Address of Issuer’s Principal | 2155 Park Boulevard | ||
| Executive Offices: | Palto Alto CA 94306 | |||
| 2(a) | Name of Person Filing: | (a) Ameriprise Financial, Inc. (“AFI”) | ||
| (b) Columbia Management Investment | ||||
| Advisers, LLC (“CMIA”) | ||||
| 2(b) | Address of Principal Business Office: | (a) Ameriprise Financial, Inc. | ||
| 145 Ameriprise Financial Center | ||||
| Minneapolis, MN 55474 | ||||
| (b) 225 Franklin St. | ||||
| Boston, MA 02110 | ||||
| 2(c) | Citizenship: | (a) Delaware | ||
| (b) Minnesota | ||||
| 2(d) | Title of Class of Securities: | Common Stock | ||
| 2(e) | Cusip Number: | 28249U105 | ||
| 3 | Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b): |
(a) Ameriprise Financial, Inc.
A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
(b) Columbia Management Investment Advisers, LLC
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
| 4 | Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person. |
AFI, as the parent company of CMIA, may be deemed to beneficially own the shares reported herein by CMIA. Accordingly, the shares reported herein by AFI include those shares separately reported herein by CMIA.
Each of AFI and CMIA disclaims beneficial ownership of any shares reported on this Schedule.
| 5 | Ownership of 5% or Less of a Class: Not Applicable |
| 6 | Ownership of more than 5% on Behalf of Another Person: Not Applicable |
| 7 | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: |
AFI: See Exhibit I
| 8 | Identification and Classification of Members of the Group: |
Not Applicable
| 9 | Notice of Dissolution of Group: |
Not Applicable
| 10 | Certification: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: January 11, 2021
| Ameriprise Financial, Inc. | ||
| By: | /s/ Paul Goucher | |
| Name: | Paul Goucher | |
| Title: Senior Vice President and Assistant General Counsel | ||
| Columbia Management Investment Advisers, LLC | ||
| By: | /s/ Paul Goucher | |
| Name: | Paul Goucher | |
| Title: Senior Vice President and Assistant Secretary | ||
| Contact Information | ||
| Mark D. Braley | ||
| Vice President | ||
| Head of Reporting and Data Management| Global Operations and Investor Services | ||
| Telephone: (617) 747-0663 | ||